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ABSTRACT
Previous studies have reported that the mice passively
sensitized with anti-dinitrophenol (DNP) IgE antibody
exhibited IgE-mediated cutaneous reaction with an
immediate phase response (IPR) at 1 h and a late
phase response (LPR) at 24 h after the challenge of
dinitrofluorobenzene (DNFB). We found that the third-
phase inflammatory reaction with intense and persist-
ing infiltration of eosinophils, named ‘very late phase
reaction (vLPR)’, was induced following IPR and LPR 
in response to DNFB in actively and passively sensi-
tized mice, and that the peak response of vLPR was at
8 days after the challenge. This reaction was slightly
observed in non-sensitized mice. Since the accumula-
tion of eosinophils in vLPR was markedly observed
when compared with that of LPR at 24 h, the vLPR may
be an important reaction in allergic diseases. The
development of vLPR was partly decreased in mast
cell-deficient WBB6F1-W/Wv mice and was absent in 
T cell-deficient BALB/c-nu/nu mice in passive sensitiz-
ation. These results indicate that the vLPR in the
triphasic cutaneous reaction may be mainly mediated
by T cells and partially by mast cells and/or IgE anti-
body, and consequently lead to an intense ear swelling
accompanying massive infiltration of eosinophils.
Key words: anti-dinitrophenol IgE antibody, dinitro-
fluorobenzene, eosinophilic infiltration, late phase
response, very late phase response.
INTRODUCTION
Recent studies have shown that allergen-induced reaction
in the skin and airway consists of two inflammatory re-
actions: an immediate phase response (IPR) and a late
phase response (LPR).1–6 Immediate phase response IPR 
is primarily caused within 1 h after the antigen exposure by
IgE-dependent activation of mast cells, resulting in release
of pro-inflammatory mediators,5 and is often followed by
an intense inflammatory reaction termed LPR.1 Late phase
response appears 3–48 h after the elicitation and is con-
sidered to be an important inflammatory reaction due to 
its similarity to the clinical manifestation of chronic allergic
diseases and its difficulty of suppression by antiallergic
drugs without side effects. The increase of mast cells is
essentially observed in IPR, while LPR is characterized by
the accumulation of inflammatory cells including neu-
trophils, mononuclear cells and eosinophils.5,6
We have shown that spikelets of Miscanthus sinensis and
some Kampo medicines inhibit the biphasic skin reaction
induced by intravenous injection of monoclonal anti-
dinitrophenol (DNP) IgE antibody in mice and subsequent
skin testing with dinitrofluorobenzene (DNFB).7–9 In the
process of our study, we recently found a third inflam-
matory-phase response following LPR, temporarily named
‘very late phase reaction (vLPR)’. In the present study, we
investigated the characteristics of vLPR and the histopatho-
logic features in mice passively sensitized with anti-DNP IgE
antibody.
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METHODS
Mice
Specific pathogen-free BALB/c mice (6-week-old),
BALB/c-nu/nu mice (6-week-old), WBB6F1- +/+ mice
(8-week-old) and WBB6F1-W/Wv mice (8-week-old)
were purchased from Japan SLC Inc., Hamamatsu,
Japan, and maintained in the Laboratory for Animal
Experiments, Research Institute for Wakan-Yaku, Toyama
Medical and Pharmaceutical University, Japan. This study
was conducted in accordance with the standards 
established by the Guidelines for the Care and Use of
Laboratory Animals of Toyama Medical and Pharma-
ceutical University, Japan.
Antigens and chemicals
Dinitrofluorobenzene was purchased from Nacalai
Tesque, Kyoto, Japan, and dissolved in 100% ethanol.
Dinitrophenol-derivation of ovalbumin (DNP-OVA) was
performed by the method of Eisen et al.10 The DNP-OVA
preparation was calculated to contain 3.5 DNP groups
per OVA molecule. Aluminum hydroxide gel (alum) 
was prepared according to the method of Levine and
Vaz11 and used as an adjuvant for the immunization with
DNP-OVA antigen. Bovine Serum Albumin (BSA) was
purchased from Sigma, St Louis, MO, USA, and dissolved
in saline before use.
Anti-DNP IgE preparation
An anti-DNP monoclonal antibody (mAb)-producing cell
line (EC1) was cultured in 10 mL of an equal volume
mixture of RPMI-1640 and Dulbecco’s modified Eagle’s
medium, with high glucose supplemented with 10% heat-
inactivated fetal bovine serum (GIBCO Laboratories, 
Life Technologies, Inc., Grand Island, NY, USA) and 
2 mmol/L glutamine until reaching confluence. The super-
natant was harvested, centrifuged at 400 g and stored at
– 80°C until used.12 The IgE antibody titer was estimated
to be 1:1024 by heterologous passive cutaneous ana-
phylaxis in rats injected intravenously with DNP-bovine
serum albumin as antigen.13
Induction of skin reaction in mouse ears
BALB/c mice were actively or passively sensitized with
DNP-OVA or anti-DNP IgE mAb, respectively. In the
passive sensitization model, mice were given an i.v. injec-
tion of a 1 mL aliquot of anti-DNP IgE mAb-containing
fluid 24 h before the DNFB challenge. Skin reaction was
elicited by applying 10 m L of 0.1%, 0.01% or 0.001%
DNFB in 100% ethanol to each side of each ear of sensi-
tized mice. The reaction to DNFB was evaluated by
measuring ear thickness using a dial thickness gauge 
(G-1 A type, Peacock; Ozaki MFG, Co., Ltd, Osaka,
Japan) immediately before the challenge and at appro-
priate intervals after. The results were expressed as
average ear swelling (increase in ear thickness, m m) ±
SD of three to five mice. For active sensitization, mice
were immunized intraperitoneally (i.p.) with 10 m g DNP-
OVA admixed with 1 mg of alum 2 weeks before the
DNFB challenge. The mice were injected in each ear with
25 m L of OVA (1 m g/m L) and BSA (1 m g/m L) solution. All
other procedures were the same as for passive sensitiza-
tion. At the time of DNFB challenge, serum IgE antibody
titer against DNP was estimated to be 1:512 by heterolo-
gous passive cutaneous anaphylaxis (hPCA).
Histologic examinations
The control and treated mice were killed under anesthetized
conditions at appropriate times after DNFB challenge, and
the ears removed. The tissues were fixed with 4% para-
formaldehyde solution and embedded in paraffin after
dehydration with a series of ethanol. The paraffin sections
were stained with hematoxylin and eosin, toluidine blue, or
naphthol AS-D chloroacetate (esterase). The correspond-
ing cells were counted under a light microscope in five
sections of 5 mm length at a magnification · 1000.
Statistical analysis
Statistical significance of difference between the groups
was determined by the Mann–Whitney’s U-test (ear swell-
ing experiment) or Student’s t-test (histologic examination).
RESULTS
Time course of IgE-mediated skin reaction in
passively or actively sensitized mice
Figure 1 shows the time course of IgE-mediated cuta-
neous reaction in mice that were passively and actively
sensitized with anti-DNP IgE antibody and DNP-OVA plus
alum, respectively. In passively sensitized mice, biphasic
skin reaction consisting of IPR and LPR was induced within
3 days after the challenge of DNFB. The peak response of
IPR was at 1 h, and LPR response at 24 h after the skin
test. These results were well consistent with the previous
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findings.7 Interestingly, a third intense cutaneous re-
action (ear swelling) following LPR was observed during
5–10 days after the DNFB challenge, peaking at
approximately 8 days. After 1 month, the ear swelling
gradually decreased to a normal level. The third-phase
reaction was temporarily designated ‘very late phase
reaction (vLPR)’. The degree of vLPR was more intense
and sustained than LPR after the skin test. Very late phase
reaction was also observed after the challenge of DNFB
in actively sensitized mice, with a similar pattern to that in
passively sensitized mice. In contrast, LPR was not
induced in non-sensitized mice, and the ear swelling at 
8 days after the challenge was much less than that of the
passively and actively sensitized mice. Thus, the pres-
ence of a third-phase cutaneous reaction (i.e., vLPR)
following IPR and LPR in response to DNFB in sensitized
mice was clearly established.
Applying OVA instead of DNFB in actively
sensitized mice
To clarify the effect of DNFB, triphasic skin reaction was
elicited by applying OVA. In active sensitization, mice
were immunized by DNP-OVA and alum and were
injected with 25 m L OVA or BSA or saline into each ear 
14 days after sensitization. Dinitrofluorobenzene was
painted in the same way as for passive sensitization.
Triphasic skin reaction was observed in the OVA-injected
ear, but vLPR disappeared in the BSA-injected ear. (Fig. 2)
Re-challenge of DNFB on IgE-mediated 
cutaneous skin reaction
The above findings indicate that triphasic skin reactions
(IPR, LPR and vLPR) were induced by DNFB challenge in
passively or actively sensitized BALB/c mice. It might be
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Fig. 1 Time course study of
dinitrofluorobenzene (DNFB)-spe-
cific skin reaction in mice. BALB/c
mice were actively or passively
sensitized with 10 m g dinitrophenol
(DNP)-ovalbumin (OVA) and 1 mg
alum or 1.0 mL anti-DNP IgE 
monoclonal antibody (mAb) prep-
aration, 2 weeks or 24 h before
antigen challenge, respectively.
Skin reaction was elicited by
applying 0.1% DNFB in 100%
ethanol to the ear skin of the
actively (n) and passively (h)
sensitized and non-sensitized (s)
mice. Each value represents mean
ear swelling ( m m) ± SD of three
mice. IPR, immediate phase res-
ponse; LPR, late phase response;
vLPR, very late phase response.
Fig. 2 Time course of triphasic skin reaction in actively sensi-
tized mice. Mice were sensitized by an intraperitoneal injection
with 10 m g dinitrophenol (DNP)-ovalbumin (OVA) and 1 mg
alum. Two weeks later they were injected with 25 m L saline (d),
25 m g OVA (s) or 25 m g BSA (h) or painted with 20 m L dinitro-
fluorobenzene (n) on their ear. Each value represents mean
± SD of three  mice.
supposed that vLPR was a result of a re-challenge of
DNFB from the paws of mice, acquired from wiping and
scratching during the process of the biphasic skin re-
action. Therefore, to confirm this, we investigated the
influence of the DNFB re-challenge in passively sensitized
mice. Skin reaction was elicited by applying 0.1% DNFB
to each ear of sensitized mice. Immediate phase
response and LPR were confirmed at 1 h and 24 h after
the challenge. On day 3, various concentrations (0.1%,
0.01% and 0.001%) of DNFB were re-challenged to the
ear skin. As shown in Fig. 3, IPR and LPR were observed
at 1 h and 24 h after the second challenge of DNFB in a
dose-dependent manner. The increased peak response
of vLPR appeared at 7 days after the first DNFB chal-
lenge, dose dependently. These results strongly suggest
that the development of vLPR was not due to the second-
ary exposure of DNFB.
Histopathologic study of skin reaction
Figure 4 shows that the number of esterase-positive cells
(neutrophils, and macrophages) slightly increased in a
close relation to the skin reaction (ear swelling) at 1 h and
24 h, but that there was no discernible change in the
number of toluidine blue-positive cells (mast cells) after
the challenge. Eosinophils were rarely seen in the ear of
passively sensitized mice before the DNFB challenge, and
conspicuously increased at 24 h (LPR) after the chal-
lenge. Although they then decreased at 4 days, a massive
infiltration into the tested ear skin was then observed at 
8 days after the challenge. In non-sensitized mice, the
number of eosinophils increased at 8 days, but was much
less than that of passively sensitized mice.
Figure 5 shows the histopathology of the ear of BALB/c
mice challenged with DNFB, following staining with
hematoxylin and eosin. One day after the challenge, infil-
tration of inflammatory cells was observed with edema 
of the dermis (Fig. 5b) when compared with skin before
the challenge (Fig. 5a). No significant change was seen
at 4 days after the DNFB challenge (Fig. 5c), but eosin-
ophils then infiltrated in conjunction with vLPR into the
challenged ear, particularly around hair roots (Fig. 5d).
Epidermal proliferation was also observed in some
lesions of ears of passively sensitized mice at 8 days.
It is therefore of major interest that the marked epi-
dermal proliferation was observed in vLPR at 8 days after
268 E TAHARA ET AL.
Fig. 3 Influence of dinitrofluorobenzene (DNFB) re-challenge
on IgE-mediated skin reaction in passively sensitized mice.
Mice were passively sensitized with anti-dinitrophenol (DNP)
IgE mAb 24 h before skin testing with 0.1% DNFB in 100%
ethanol. On day 3 after the first challenge, mice were re-
challenged with 0.001% (h), 0.01% (s), 0.1% DNFB (n) or
ethanol alone (d) for skin testing. Each value represents mean
ear swelling (m m) ± SD of three mice.
Fig. 4 Histopathologic analysis of skin reaction in passively
sensitized mice. Mice received intravenous injection of 1.0 mL
anti-dinitrophenol (DNP) IgE mAb preparation 24 h before skin
testing with 0.1% dinitrofluorobenzene (DNFB) in 100%
ethanol. After DNFB challenge, the mice were killed and 
the ears were removed for histopathologic examination. The
thin sections were stained with toluidine blue, naphthol-AS-D-
chloroacetate esterase or hematoxylin and eosin. The toluidine
blue-positive (h), esterase-positive ( ), eosinophilic cells ( )
in passively sensitized mice and eosinophilic cells in non-
sensitized mice at 0 and 8 days (j) were manually counted
under a light microscope in five sections of 5 mm length. Each
value represents mean ± SD of five sections. *P < 0.05 using
the Student’s t-test.
the challenge. Previous studies indicated that the infil-
tration of mast cells may play an essential role in IPR, and
that LPR may be primarily elicited by the participation of
other cells, including macrophages and/or neutrophils.7
The present study revealed that eosinophils are promi-
nently involved in the development of vLPR.
Elicitation of IgE-mediated skin reaction in
mast cell- or T cell-deficient mice
To examine the participation of mast cells and T cells in
vLPR following epicutaneous challenge, we investigated
the triphasic cutaneous reaction in genetically deficient
mice that were passively sensitized with anti-DNP IgE
antibody. Immediate phase response was absent in mast
cell-deficient WBB6F1-W/Wv mice when compared with
their congenital litter mates W/W +/+, but LPR was suffi-
ciently observed (Fig. 6). On the other hand, vLPR was
apparently attenuated in WBB6F1-W/Wv mice. In non-
sensitized W/W +/+ mice, diminished vLPR was elicited
when compared with passively sensitized W/W +/+
mice. But vLPR was not observed in non-sensitized W/Wv
mice.
As shown in Fig. 7, both IPR and LPR were surveyed
after the DNFB challenge in passively sensitized BALB/c
nu/nu mice, and the degree of the response was greater
than in BALB/c mice. In contrast, vLPR had essentially dis-
appeared in BALB/c nu/nu mice, but was strongly present
in BALB/c mice. In non-sensitized BALB/c nu/nu mice, a
slight increase of ear swelling was detected, conforming
with vLPR.
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Fig. 5 Histopathology of skin reaction in passively sensitized mice. Mice received intravenous injection of 1.0 mL anti-dinitro-
phenol (DNP) IgE mAb preparation 24 h before skin testing with 0.1% dinitrofluorobenzene (DNFB) in 100% ethanol. After DNFB
challenge, the mice were killed and the ears were removed for histopathologic examination. Thin sections were stained with hema-
toxylin and eosin. (a) Skin of mouse ear before DNFB challenge. (b) At 24 h after challenge; moderate edema of the dermis and
inflammatory cell infiltrations can be seen. (c) At 4 days after challenge; no significant changes compared to normal skin can be
seen. (d) At 8 days after the challenge; marked infiltration of eosinophils (arrows) and epidermal proliferation are observed.
DISCUSSION
Several investigations have reported that mice passively
sensitized with IgE-containing solution exhibited immed-
iate and late phase skin reactions to the subsequent
challenge of antigen.1,2,5,6 The inflammation associated
with LPR is of great clinical importance as it accounts for
the morbidity and severity of chronic allergic diseases like
bronchial asthma, rhinitis and atopic dermatitis.14 Late
phase response has been shown to accompany poly-
morphic inflammatory infiltrates such as neutrophils,
eosinophils, and lymphocytes.5,6 Particularly, eosinophils
are responsible for this phenomenon in IgE-mediated
skin reaction as important effector cells.2,5,6,15 However,
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Fig. 6 Time course study of
IgE-mediated skin reaction 
in passively sensitized 
WBB-6F1 mice. Mast cell-
deficient WBB6F1-W/Wv mice
(s) and their litter mates
W/W +/+ (d) were passively 
sensitized with 1.0 mL anti-
dinitrophenol IgE mAb
preparation 24 h before skin
testing with 0.1% dinitrofluo-
robenzene (DNFB) in 100%
ethanol and WBB6F1-W/Wv
(h) and W/W +/+ (j) mice
were non-sensitized. Each
value represents mean ear
swelling ( m m) ± SD of three
mice.
Fig. 7 Time course study 
of IgE-mediated skin reaction
in passively sensitized BALB/c-
nu/nu mice. T cell-deficient
BALB/c-nu/nu mice (s) and
their litter mates (d) were
passively sensitized with 1.0 mL
anti-DNP IgE mAb preparation
24 h before skin testing with
0.1% dinitrofluorobenzene
(DNFB) in 100% ethanol and
BALB/c-nu/nu (h) and BALB/c
(j) mice were non-sensitized.
Each value represents mean
± SD of three mice.
many studies have reported that LPR in IgE-mediated skin
reaction was observed at most 72 h after the antigen
exposure.5–8,15–17
In the present study, we noticed that passive sensitiz-
ation with anti-DNP IgE antibody followed by the challenge
of DNFB to mouse ears can induce the triphasic cuta-
neous reactions of IPR, LPR and vLPR, peaking at 1 h, 
24 h and 8 days after antigen challenge, respectively
(Fig. 1). The third-phase inflammatory response was
more intense for ear swelling than LPR, and persisted for
longer periods. Very late phase response was markedly
induced in actively sensitized mice as well as passively
sensitized mice, but was only slightly observed in non-
sensitized mice. The triphasic cutaneous reactions ap-
peared with injection of OVA in actively sensitized mice,
which indicates that vLPR may be due to an antigen
(hapten)-specific response in sensitized mice, but not 
specific for DNFB.
The peak response of vLPR was observed at 7 or 8 days
after the challenge of DNFB, even with a re-challenge on
day 3 after the first challenge (i.e., following IPR and LPR;
Fig. 3). This indicates that the induction of vLPR may not
depend on the re-contact with DNFB, but may result from
internal factors or their related cells produced by the first
challenge.
Histopathologic examination revealed massive infiltra-
tion of eosinophils in vLPR at 8 days, suggesting that
eosinophils are responsible for the development of this
reaction. However, no marked increase of eosinophils in
peripheral blood was observed at the time of vLPR in pas-
sively sensitized mice (data not shown). Although many
studies have shown that eosinophilic infiltration was
observed in LPR at 24 h after skin test,5,6,16 our present
results indicate that the accumulation of eosinophils at
vLPR was more marked than at LPR in passively sensitized
mice. This suggests that vLPR with eosinophil infiltration
actually represents an important inflammatory reaction in
allergic diseases. The LPR seen in bronchial disease18–21
may be very similar to the vLPR in our study. Especially,
Hutson et al. 198820 have reported two delayed broncho-
constrictor events, including a peak response at 17 h
after challenge and a further response at 72 h with
increased eosinophils in BAL from guinea-pig in an
asthma model. Also, vLPR is apparently different from
post late phase reaction (pLPR), meaning non-allergic
hyperactivity in bronchial asthma,22 because the third
inflammation continued for very long periods and more
intensely than LPR.
In genetically mast cell-deficient WBB6F1-W/Wv mice
with mutation of the W/c-kit locus, IPR was absent but LPR
was strongly manifested after DNFB challenge (Fig. 6).
Very late phase response was also present, but to a lesser
degree than in WBB6F1- +/+ mice. This finding indi-
cates that mast cells or mediators originating from them
may be a prerequisite for the development of vLPR.
Because mutations in the W/c-kit locus result in the
absence of the c-kit receptor or the production of abnor-
mal receptors,23–25 stem-cell factor, a ligand for the c-kit
receptor, may be partly associated with the development
of allergic response. Diminished vLPR was detected in
non-sensitized W/W +/+ mice than in sensitized W/W
+/+ mice, but disappeared in non-sensitized W/Wv
mice. These findings suggest that the presence of IgE
antibody might enhance the development of vLPR. On
the other hand, both IPR and LPR were induced after
DNFB challenge in T cell-deficient BALB/c-nu/nu mice
passively sensitized with anti-DNP IgE antibody, but vLPR
was almost completely absent, in contrast to BALB/c
mice. These results clearly indicate that LPR is a T cell-
independent response, while vLPR is mainly mediated by
T cells and factors derived from them. Because T cells
and eosinophils have been reported to accumulate in the
skin of a patient with atopic dermatitis,26–28 further study
will be needed to examine the close association between
T cells and eosinophils in the skin reaction. A slight
increase of ear swelling in non-sensitized mice was
evident during 6–9 days, which might have been depen-
dent on mast cell or its mediators released by the irritant
chemical effect of DNFB. Allergic reaction has been con-
sidered to be divided into two separate categories:
IgE-mediated response and delayed type hypersensitivity
(DTH). Very late phase response might be a delayed type
hypersensitivity (DTH), which is so-called ‘flare-up’ in the
dermatology field, and weal and flare phenomenon
observed at the late phase of the patch test. If vLPR were
DTH, it might be considered to be DTH-enhanced by the
presence of IgE. Therefore, in vLPR two allergic cate-
gories might be observed at the same time.
In the present study, we demonstrated for the first time
that third-phase inflammatory response with massive
eosinophilic infiltration, designated vLPR, was induced
by the DNFB challenge in passively and actively sensi-
tized mice. Very late phase response in the triphasic
cutaneous reaction was mainly mediated by T cells, par-
tially dependent on mast cells and/or IgE antibody, and
obviously different from LPR. Although it has not been
clarified what kinds of chemical mediators are involved
in the formation of vLPR, our preliminary study indicates
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that the expression of granulocyte–macrophage colony
stimulating factor (GM-CSF) and regulated upon activa-
tion, normal T cell expressed and secreted (RANTES)
mRNA in mouse ears was detected at vLPR by the reverse
transcriptase polymerase chain reaction method. To under-
stand the pathologic significance of vLPR in this triphasic
cutaneous reaction, further studies will be required to
clarify the mechanism underlying the development of
vLPR, especially the marked infiltration of eosinophils and
the pathologic relation between T cells and eosinophils.
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